Brian P Callahan

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2021
Publications (10 Years): 7

Top Topics

Prostate Cancer

Structural Basis

Top Venues

Journal of the American Chemical Society

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew G Wagner, Robert T Stagnitta, Zihan Xu, John L Pezzullo, Nabin Kandel, José-Luis Giner, Douglas F Covey, Chunyu Wang, Brian P Callahan
Nanomolar, Noncovalent Antagonism of Hedgehog Cholesterolysis: Exception to the "Irreversibility Rule" for Protein Autoprocessing Inhibition. Biochemistry 61 (11) (2021)
Carl J Smith, Andrew G Wagner, Robert T Stagnitta, Zihan Xu, John L Pezzullo, José-Luis Giner, Jian Xie, Douglas F Covey, Chunyu Wang, Brian P Callahan
Subverting Hedgehog Protein Autoprocessing by Chemical Induction of Paracatalysis. Biochemistry 59 (6) (2020)
Brian P Callahan, Daniel A Ciulla, Andrew G Wagner, Zihan Xu, Xiaoyu Zhang
Specificity Distorted: Chemical Induction of Biological Paracatalysis. Biochemistry 59 (38) (2020)
Jing Zhao, Daniel A Ciulla, Jian Xie, Andrew G Wagner, Drew A Castillo, Allison S Zwarycz, Zhongqian Lin, Seth Beadle, José-Luis Giner, Zhong Li, Hongmin Li, Nilesh K Banavali, Brian P Callahan, Chunyu Wang
General Base Swap Preserves Activity and Expands Substrate Tolerance in Hedgehog Autoprocessing. Journal of the American Chemical Society 141 (46) (2019)
Xiaoyu Zhang, Zihan Xu, Dina S Moumin, Daniel A Ciulla, Timothy S Owen, Rebecca A Mancusi, José-Luis Giner, Chunyu Wang, Brian P Callahan
Protein-Nucleic Acid Conjugation with Sterol Linkers Using Hedgehog Autoprocessing. Bioconjugate chemistry 30 (11) (2019)
Daniel A Ciulla, Michael T Jorgensen, José-Luis Giner, Brian P Callahan
Chemical Bypass of General Base Catalysis in Hedgehog Protein Cholesterolysis Using a Hyper-Nucleophilic Substrate. Journal of the American Chemical Society 140 (3) (2017)
Brandon M Bordeau, Daniel A Ciulla, Brian P Callahan
Hedgehog Proteins Consume Steroidal CYP17A1 Antagonists: Potential Therapeutic Significance in Advanced Prostate Cancer. ChemMedChem 11 (18) (2016)